How a phlebotomy supervisor inspires a happy, positive workplace

Ever since she joined Labcorp 17 years ago, Lekeisha Waiters has known her ultimate career goal was to be in leadership. Waiters’ dream was realized last year, when she was promoted to Phlebotomy Supervisor. In this role, she oversees operations for 11 patient service centers in the Southeast, taking pride in her locations’ consistently high customer satisfaction scores.

How this marketing writer tackled a major project in her first year

Despite having joined Labcorp less than a year ago, Allie Strickler has already proved herself a creative force to be reckoned with. Hired as a marketing writer whose focus would be on provider-based content, it wasn’t long before Strickler became an integral part of the team. 

Labcorp to Host Investor Day on September 14, 2023

BURLINGTON, N.C. , July 31, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services,  today announced it will host an Investor Day on Thursday, September 14, 2023 , in New York City , beginning at 1:00 p.m.

How this phlebotomist turned her job into a career of empowering others

16 years ago, Jenn Knowles-Mommer found herself stressed and unhappy with the hospital shifts she was working, and she wanted a change.

The impact of single gene testing (SGT) on subsequent comprehensive genomic profiling (CGP) success in community oncology practice for advanced non-small cell lung cancer (NSCLC)

Results from a prospective observational reference laboratory testing programView graphical summary page of abstract  

Labcorp Announces 2023 Second Quarter Results

Company Provides Full-Year Guidance Labcorp completed the spin-off of Fortrea on June 30 , which is treated as discontinued operations in the historical financials Announced a $1.0 billion accelerated share repurchase program Drove growth through new and expanded healthcare system partnerships

Labcorp OnDemand Offers Menopause Test to Consumers

Labcorp's Menopause Test and Menopause Support Program provide women with insights to guide their healthcare decisions BURLINGTON, N.C. , July 24, 2023 /PRNewswire/ --  Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it now offers menopause

First-in-human (FIH) phase I dose escalation study (Part A) of the first oral allosteric modulator of phosphoinositide 3-kinase inhibitor delta (PI3Kδ) roginolisib in patients with advanced cancer and dose confirmation in Uveal Melanoma (Part B)